Position in AUTL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$479,779
+$140,597 QoQ
Shares Held
299,862
+22.0% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 84 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUTL Over Time
Shares Held
Position Value (USD)
Derivatives in AUTL
reported options exposure · as of Jun 30, 2026CallValue
$337,920
CallShares
211,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. AUTL ranks #117 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in AUTL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479,779 | 299,862 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $337,920 | 211,200 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $232,530 | 168,500 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $339,182 | 245,785 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,355,189 | 681,000 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $20,538 | 12,600 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $1,425,391 | 874,474 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $158,863 | 102,493 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $26,486 | 11,271 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $324,596 | 93,275 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $482,608 | 75,644 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $434,667 | 67,495 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $32,601 | 13,992 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $55,370 | 23,265 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $176,411 | 95,876 | Shares | Defined | 2023-05-16 | |
| 2022-09-30 | $41,278 | 19,289 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $41,649 | 14,717 | Shares | Defined | 2022-08-16 | |
| 2021-12-31 | $69,296 | 13,352 | Shares | Defined | 2022-02-15 | |
| 2021-06-30 | $196,464 | 29,588 | Shares | Defined | 2021-08-16 | |
| 2020-06-30 | $217,847 | 13,590 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||